The University of Notre Dame Australia

ResearchOnline@ND
Medical Papers and Journal Articles

School of Medicine

2017

Association of cerebral small vessel disease burden and health-related
quality of life after acute ischemic stroke
Yan Liang
Yang-Kun Chen
Min Deng
Vincent C.T. Mok
De-Feng Wang

See next page for additional authors

Follow this and additional works at: https://researchonline.nd.edu.au/med_article
Part of the Medicine and Health Sciences Commons
This article was originally published as:
Liang, Y., Chen, Y., Deng, M., Mok, V. C., Wang, D., Ungvari, G. S., Chu, C. W., Kamiya, A., & Tang, W. (2017). Association of cerebral
small vessel disease burden and health-related quality of life after acute ischemic stroke. Frontiers in Aging Neuroscience, 9.
Original article available here:
https://dx.doi.org/10.3389/fnagi.2017.00372

This article is posted on ResearchOnline@ND at
https://researchonline.nd.edu.au/med_article/886. For more
information, please contact researchonline@nd.edu.au.

Authors
Yan Liang, Yang-Kun Chen, Min Deng, Vincent C.T. Mok, De-Feng Wang, Gabor S. Ungvari, Chiu-wing W.
Chu, Akane Kamiya, and Wai-Kwong Tang

This article is available at ResearchOnline@ND: https://researchonline.nd.edu.au/med_article/886

This is an Open Access article distributed in accordance with the Creative Commons Attribution 4.0
International license (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original author and source are credited.
See: https://creativecommons.org/licenses/by/4.0/
This article originally published in Frontiers in Aging Neuroscience available at:
https://dx.doi.org/10.3389/fnagi.2017.00372
Liang, Y., Chen, Y., Deng, M., Mok, V.C.T., Want, D., Ungvari, G.S., Chu, C.W., Kamiya, A., and Tang,
W. (2017) Association of cerebral small vessel disease burden and health-related quality of life after
acute ischemic stroke. Frontiers in Aging Neuroscience, 9. doi: 10.3389/fnagi.2017.00372

ORIGINAL RESEARCH
published: 13 November 2017
doi: 10.3389/fnagi.2017.00372

Association of Cerebral Small Vessel
Disease Burden and Health-Related
Quality of Life after Acute Ischemic
Stroke
Yan Liang 1 , Yang-Kun Chen 2 , Min Deng 3 , Vincent C. T. Mok 4 , De-Feng Wang 3 ,
Gabor S. Ungvari 5 , Chiu-wing W. Chu 3 , Akane Kamiya 6 and Wai-Kwong Tang 1,7 *
1

Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong, China, 2 Department of Neurology, Dongguan
People’s Hospital, Dongguan, China, 3 Department of Imaging and Interventional Radiology, The Chinese University of
Hong Kong, Hong Kong, China, 4 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong
Kong, China, 5 Australia/Marian Centre, University of Notre Dame, Perth, WA, Australia, 6 Department of Rehabilitation,
Sagamihara Minami Hospital, Sagamihara, Japan, 7 Shenzhen Research Institute, The Chinese University of Hong Kong,
Shenzhen, China

Objective: Cerebral small vessel disease (SVD) is associated with increased mortality,

disability and cognitive decline, depression in stroke survivors. This study examined
the association between SVD burden, defined by a combination of SVD markers, and
health-related quality of life (HRQoL) in acute ischemic stroke.
Methods: Patients admitted with acute ischemic stroke of any etiology were
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prospectively screened between January 2010 to December 2014 and enrolled in
the study if they met study entry criteria. HRQoL was evaluated with the 12-item
Stroke Specific Quality of Life (SSQoL) at 3 months after the onset of acute ischemic
stroke. SVD was ascertained by the presence of any of the SVD markers including
lacune, white matter hyperintensities (WMH), cerebral microbleeds (CMB) and enlarged
perivascular spaces (EPVS) in the basal ganglia or their combinations on brain magnetic
resonance imaging (MRI). The presence of each individual marker scored 1 point and
was summed up to generate an ordinal “SVD score” (0–4) capturing total SVD burden.
Linear regression was used to determine the associations between SVD burden and
HRQoL.
Results: Of the743 acute ischemic stroke patients that formed he study sample (mean

age: 66.3 ± 10.6 years; 41.7% women), 49.3%, 22.5%, 16.0%, 9.2% and 3.1% had
SVD scores of 0, 1, 2, 3 and 4, respectively. After adjusting for demographic, clinical and
imaging variables, the SVD score was independently associated with lower overall score
of SSQoL (B = −1.39, SE = 0.56, p = 0.01), and its domains of mobility (B = −0.41,
SE = 0.10, p < 0.001) and vision (B = −0.12, SE = 0.06, p = 0.03). Acute infract volume
(B = −1.44, SE = 0.54, p = 0.01), functional independence (B = 5.69, SE = 0.34,
Abbreviations: BI, Barthel Index; CMB, cerebral microbleeds; EPVS, enlarged perivascular spaces; FOV, field of view;
GDS, Geriatric Depression Scale; HADS-AS, Hospital Anxiety Depression Scale-Anxiety Subscale; HRQoL, health-related
quality of life; IQR, interquartile ranges; LSNS, Lubben Social Network Scale; MMSE, Mini-Mental State Examination;
NIHSS, National Institutes of Health Stroke Scale; SD, standard deviations; SSQoL, Stroke Specific Quality of Life; SVD,
small vessel disease; TE, echo delay times; TR, repetition time; WMH, white matter hyperintensities.
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p < 0.001) and anxious (B = −1.13, SE = 0.23, p < 0.001) and depressive symptoms
(B = −3.41, SE = 0.22, p < 0.001) were also the significant predictors of the overall
score of SSQoL.
Conclusion: The brain’s SVD burden predicts lower HRQoL, predominantly in domains
of mobility and vision at 3 months after acute ischemic stroke. The evaluation of SVD
burden could facilitate developing individual treatment strategies.
Keywords: cerebral small vessel disease, white matter hyperintensities, lacune, cerebral microbleed, enlarged
perivascular space, quality of life, stroke

INTRODUCTION

between January 2010 and December 2014 were consecutively
screened for the following study entry criteria: having MRI scans
on admission, Cantonese speakers and of Chinese ethnicity,
having sufficient language, auditory and visual abilities to allow
the assessments, having no history of neurological diseases,
alcoholism, dementia or severe comorbid medical diseases and
no recurrence of the index stroke before the 3-month follow up.
The study protocol was approved by the Joint Chinese
University of Hong Kong-New Territories East Cluster Clinical
Research Ethic Committee. The consents obtained from all the
participants were both informed and written.

Cerebral small vessel disease (SVD) is a condition of clinical,
neuroimaging and neuropathological presentations that causes
the damage to the brain’s small perforating vessels (Wardlaw
et al., 2013a). The markers of SVD on magnetic resonance
imaging (MRI) are white matter hyperintensities (WMH),
lacunes, cerebral microbleeds (CMB) and enlarged perivascular
spaces (EPVS; Wardlaw et al., 2013a). As these markers are
closely associated with increased mortality (Song et al., 2017),
poor physical function (Arauz et al., 2003; Charidimou et al.,
2016; Sato et al., 2016; Senda et al., 2016; Yang et al., 2016;
Helenius et al., 2017), stroke recurrence (Arauz et al., 2003; Lau
et al., 2017), cognitive decline (Huijts et al., 2013; Uiterwijk et al.,
2016) and depression (Zhang et al., 2016) after stroke, SVD is
thought to be a poor prognostic marker of stroke (Kim and Lee,
2015).
Health-related quality of life (HRQoL) is an outcome measure
encompassing both physical and mental health. HRQoL is
one of the common measure of stroke outcome (Ali et al.,
2013). Understanding the factors influencing HRQoL after stroke
may help to guide rehabilitation strategies for stroke survivors.
Associations between WMH (Tang et al., 2013), CMB (Tang
et al., 2011) and lower HRQoL have been reported in stroke
survivors, indicating that SVD may have an impact on poststroke
HRQoL. The common limitation of all the above studies on SVD
is that they have not examined the total SVD burden. A ‘‘total
SVD score’’ is constructed by summing up all individual SVD
markers into a single measure that is thought to better represent
the total brain damage from SVD (Staals et al., 2014). Several
recent studies have suggested a role for SVD burden in predicting
mortality (Song et al., 2017), unfavorable functional outcome
(Yang et al., 2016; Arba et al., 2017), cognitive decline (Huijts
et al., 2013; Uiterwijk et al., 2016) and depression (Zhang et al.,
2016) after stroke. However, to the best of our knowledge, the
association between SVD burden and poststroke HRQoL has
never been investigated, which gave the impetus to examine this
relationship at 3 months after the index acute ischemic stroke in
a large cohort of systematically screened and assessed patients.

Collection of Demographic and Clinical
Data
Within 2 days of admission for the index stroke, a research
nurse collected basic demographic data (age, sex and years
of education) and medical history including hypertension,
diabetes mellitus, hyperlipidemia and previous stroke and
assessed the stroke severity using the National Institutes of
Health Stroke Scale (NIHSS). Three months after the index
stroke, the Chinese version of the Stroke Specific Quality of
Life (SSQoL) questionnaire, a valid scale specifically developed
to measure poststroke HRQoL (Wang et al., 2003), was
administered to all patients. The SSQoL comprises 49 items
covering 12 domains, with each item rated on a 5-point
Likert scale ranging from ‘‘completely true’’ to ‘‘not true
at all’’. Total and domain scores were generated with a
higher score indicating better health condition. The total score
ranges from 49 to 245 while the domain scores vary from
3 to 30. The Barthel Index (BI), Lubben Social Network
Scale (LSNS), Mini-Mental State Examination (MMSE), Hospital
Anxiety Depression Scale-Anxiety Subscale (HADS-AS) and the
15-item Geriatric Depression Scale (GDS) were used to assess
functional independence, social support, cognitive function and
anxiety and depressive symptoms at the 3-month follow-up,
respectively.

Brain MRI Acquisition
All patients were scanned on a 1.5-T MRI system (Sonata;
Siemens Medical) within 1 week of the index admission.
The following sequences were performed: diffusion-weighted
imaging, gradient echo, T1- and T2-weighted and fluid
attenuated inversion recovery. Diffusion-weighted imaging
spin-echo echo-planar imaging (long repetition time [TR]/echo
delay times [TE]/excitation = 180/122/4; matrix = 128 × 128;

MATERIALS AND METHODS
Study Sample
Patients with first-ever or recurrent acute ischemic stroke of any
etiology admitted to the Stroke Unit of Prince of Wales Hospital
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field of view (FOV) = 230 mm; slice thickness/gap = 5 mm/1 mm;
echo-planar imaging factor = 90; acquisition time = 55 s)
with three orthogonally applied gradients was used with
b values of 1000 and 500. Axial gradient echo images were
acquired as the second sequence, with imaging parameters
of TR/TE/excitation = 350/30/2; flip angle of 30◦ ; slice
thickness/gap = 5 mm/0.5 mm; FOV = 230 mm; matrix
256 × 256; and acquisition time = 5 min and 4 s. Axial SE
T1 (TR/TE/excitation = 425/14/2; FOV = 23 0 mm; slice
thickness/gap = 5 mm/0.5 mm; matrix = 256 × 256; and
acquisition time = 4 min and 28 s). Turbo spin-echo T2 images
were also acquired (TR/TE/excitation = 2500/120/1; turbo factor
of 15; FOV = 230 mm; slice thickness/gap = 5 mm/0.5 mm;
matrix of 256 × 256; and acquisition time = 1 min
and 39 s) and axial FLAIR sequences (TR/TE/inversiontime/excitation = 9000/117/2500/2; turbo factor of 31;
FOV = 230 mm; slice thickness/gap = 5 mm/1 mm;
matrix = 256 × 256; acquisition time = 3 min and 20 s).

Multivariate linear regression analyses were used to investigate
the associations between SVD burden and overall SSQoL and
its domains adjusting for age, sex, education, history of stroke,
hypertension, diabetes mellitus and hyperlipidemia, scores of
NIHSS on admission, BI, HADS-AS, GDS, MMSE, acute
infarcts’ volume, acute infarcts’ locations (cortical, subcortical
and infratentorial), presence of old infarcts with a forward
selection method. Due to the skewness of acute infarcts’
volume, they were categorized into four degrees based on
the quartile (Degree 1: = 0 mL; Degree 2: 0.01–0.50 mL;
Degree 3: 0.51–1.76 mL; Degree 4: >1.76 mL; Lin et al.,
2017) and then made them enter all the regression models.
The models did not involve any multicollinearity since all
predictors showed a variance inflation factor of <10. IBM
SPSS Statistics, Version 20.0 software was used for all the
above analyses. The level of significance was set at 0.05 (twotailed).

SVD Total Score

RESULTS

All MRI scans were reviewed by a qualified neurologist (YL)
blinded to all other data. The neuroimaging markers of SVD were
all defined according to the STRIVE guideline (Wardlaw et al.,
2013a). Deep WMH and periventricular WMH were assessed
with the Fazekas scale ranging from 0 to 3 (Deep WMH: 0 = no
lesions, 1 = punctate foci, 2 = beginning confluency of foci,
3 = large confluent areas; Periventricular WMH: 0 = no lesions,
1 = caps or thin line, 2 = smooth halo, 3 = extension to white
matter; Fazekas et al., 1987). Extensive WMH was defined if deep
WMH were scored 2 or 3, or periventricular WMH were scored
3. The severity of EPVS in the basal ganglia was rated according
to the number of spaces in a slice from one side containing the
maximum amount of EPVS: 0 = none; 1 = 1–10; 2 = 11–20;
3 = 21–40; 4 = >40 (Potter et al., 2015). The number of the
CMB and lacune were recorded. Furthermore, an ordinal scale
validated by Staals et al (Staals et al., 2014) was adopted to
calculate the total SVD burden. Briefly, one point was awarded if
any lacune or CMB were present, or EPVS in basal ganglia scored
2–4, or extensive WMH (respectively. The four subscores were
then summed up to generate a total SVD score that ranged from
0 to 4.

Characteristics of the Study Sample
The recruitment flow chart is shown in Figure 1. Only 1999
(35.1%) patients of all admissions with acute ischemic stroke
during the study period received MRI scans due to limited access
to the MRI machine. Eventually, 743 of these 1999 patients
met the inclusion criteria and comprised the final sample.
The age did not differ between the included and excluded
patients (66.3 ± 10.6 vs. 67.0 ± 13.1; p = 0.200), but the
excluded patients were more likely to be female (61.3% vs. 38.7%;
p = 0.043) and had more severe stroke indicated by higher
NIHSS scores on the index admission (3 (1–6) vs. 3 (1–5);
p < 0.001).
The demographic, clinical and MRI characteristics of the
whole sample are detailly listed in Table 1. Patients had
milder anxious (HAD-AS: 0 (0–3)) and depressive (GDS: 2
(1–5)) symptoms, while relatively good functional independence
(BI: 19.1 ± 2.5) and cognitive function (MMSE: 26.9 ± 3.2)
at 3 months after stroke. Almost half of the patients did
not present with any acute infarct or had a low acute
infarct volume (≤0.50 mL). About half of the study sample
presented without SVD or with a low SVD burden (SVD
score = 0). Of those who had moderate to severe SVD
burden (SVD score > 0), 22.5%, 16.0%, 9.2% and 3.1%
patients had a SVD score of 1, 2, 3 and 4, respectively
(Table 1).
The SSQoL scores are listed in Table 2. The mean SSQoL total
score was 218.8 ± 26.9 with a range of 64–245. Thus, the study
sample compromised patients with milder stroke, and relatively
favorable clinical outcomes.

Other Brain MRI Data
Brain infarcts were detected on T1-weighted images presenting
with signals similar to cerebrospinal fluid and diameters
exceeding 3 mm. The volumes of infarcts was measured, and
the contour of the acute infarcts with restricted water diffusion
(identified on diffusion-weighted imaging with b values of 1000)
were manually drawn. The total volume was generated by
multiplying the total area by the sum of the slice thickness
and gap. The locations (cortical, subcortical and infratentorial)
of acute infarct and the presence of old infarct were also
recorded.

Association between SVD and SSQoL
The associations between SVD burden and overall SSQoL and
its domains were estimated with multivariate regression models
adjusted for demographic, clinical and imaging characteristics
(Table 3 and Supplementary Table S1). The models in which
SVD score was significantly associated with SSQoL are displayed

Statistical Analysis
Data are presented as means ± standard deviations, medians
(interquartile ranges or ranges), or proportions as appropriate.
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FIGURE 1 | Flow chart of recruitment.

Table S1). Acute infarcts’ volume was significantly associated
with reduced overall SSQoL (B = −1.39, SE = 0.56, p = 0.01;
Model 1, Table 1), and the domains of family-role (B = −0.20,
SE = 0.09, p = 0.03; Model 2, Supplementary Table S1)
and social-role (B = −0.36, SE = 0.15, p = 0.02; Model 8,
Supplementary Table S1). Cortical acute infarcts were associated
with mood (B = −0.64, SE = 0.31, p = 0.04; Model 5,
Supplementary Table S1), whereas infratentorial acute infarcts
correlated with overall SSQoL (B = −1.39, SE = 0.56, p = 0.01;
Model 1, Table 3), the energy (B = −1.00, SE = 0.40, p = 0.01;
Model 1, Supplementary Table S1), mobility (B = −0.67,
SE = 0.32, p = 0.04; Model 4, Supplementary Table S1) and
thinking domain scores (B = −0.24, SE = 0.11, p = 0.03;
Model 9, Supplementary Table S1). Other significant predictors
of domain specific SSQoL were age, female sex and hypertension
(Supplementary Table S1). In short, the overall or domain scores
of SSQoL were affected by a wide range of demographic, clinical
and MRI factors.

in Table 3. The SVD score was a significant predictor of
the SSQoL total score (B = −1.39, SE = 0.56, p = 0.01,
Model 1), and domain scores of mobility (B = −0.49, SE = 0.10,
p < 0.001, Model 2) and vision (B = −0.12, SE = 0.06,
p = 0.03, Model 3) after adjusting for confounding factors,
with a R2 of 0.63, 0.53, and 0.10 for Model 1, 2 and 3,
respectively (Table 3). SVD burden negatively affected the overall
SSQoL, and the domains of mobility and vision. Some of the
individual SVD markers, namely extensive WMH (B = −3.02,
SE = 1.33, p = 0.02) and moderate to severe EPVS (B = −3.29,
SE = 1.37, p = 0.02) were showed to be significant predictors
of SSQoL, whilst CMB (p = 0.05) and lacunes (p = 0.77)
did not showed significant associations with SSQoL (data not
presented).
In conclusion, only WMH and EPVS showed significant
association with HRQoL when the markers were considered
separately; however, SVD burden was a significant predictor of
HRQoL when the four individual markers were combined into a
‘‘SVD score’’.

DISCUSSION

Association between Other Characteristics
and SSQoL

The main finding of this study is that SVD burden capturing the
total brain damage resulting from SVD was independently and
negatively associated with HRQoL, particularly in the mobility
and vison domains. To the best of our knowledge, this was the
first study that investigated the association between SVD burden
and stroke survivors’ HRQoL.

The associations between each domain of SSQoL and all the
potential predictors are demonstrated in Supplementary Table
S1. Functional independence (BI), depressive (GDS) and anxiety
symptoms (HADS-AS) were the three most consistent predictors
of both overall SSQoL and its domains (Table 1; Supplementary
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TABLE 2 | Values of total and dimensional SSQoL scores in the whole study
sample (n = 743).

TABLE 1 | Demographic, clinical and magnetic resonance imaging (MRI)
characteristics of the study sample at the 3 months follow up poststroke.
Characteristics

N = 743

Age, years, mean ± SD
Women, n (%)
Education, years, mean ± SD
Married, n (%)
Previous stroke, n (%)
Hypertension, n (%)
Diabetes mellitus, n (%)
Hyperlipidemia, n (%)
NIHSS score on admission, median (IQR)
BI score, mean ± SD
LSNS score, mean ± SD
HADS-AS score, median (IQR)
GDS score, median (IQR)
MMSE score, mean ± SD
Acute infarct volume groups
Degree 1 (= 0 mL)
Degree 2 (0.10–0.50 mL)
Degree 3 (0.51–1.76 mL)
Degree 4 (>1.76 mL)
Cortical acute infarct, n (%)
Subcortical acute infarct, n (%)
Infratentorial acute infarct, n (%)
Presence of old infarct, n (%)
Markers of SVD
Lacune, n (%)
Extensive WMH, n (%)
Moderate to severe EPVS in the basal ganglia, n (%)
CMB, n (%)
SVD score 0, n (%)
SVD score 1, n (%)
SVD score 2, n (%)
SVD score 3, n (%)
SVD score 4, n (%)
Duration from stroke onset to follow-up, days, median (IQR)

66.3 ± 10.6
310 (41.7)
6.7 ± 4.4
565 (76.0)
75 (10.2)
486 (66.4)
217 (29.6)
296 (40.4)
3 (1–5)
19.1 ± 2.5
28.5 ± 8.9
0 (0–3)
2 (1–5)
26.9 ± 3.2

SSQoL total score
Energy
Family role
Language
Mobility
Mood
Personality
Self-care
Social role
Thinking
Upper extremity function
Vision
Work

Mean ± SD

Median (Range)

218.8 ± 26.9
10.3 ± 4.1
13.1 ± 3.1
24.3 ± 1.8
27.5 ± 4.4
22.7 ± 4.6
12.5 ± 3.5
24.2 ± 2.6
22.1 ± 5.3
11.6 ± 3.7
24.0 ± 2.9
14.3 ± 1.7
12.2 ± 3.5

227 (64–245)
12 (3–15)
15 (3–15)
25 (5–25)
30 (6–30)
25 (5–25)
15 (3–15)
25 (5–25)
25 (5–25)
12 (3–15)
25 (5–25)
15 (3–15)
13 (3–15)

SSQoL, Stroke-Specific Quality of Life.

249 (33.5)
122 (16.4)
185 (24.9)
187 (25.2)
143 (19.2)
284 (38.2)
118 (15.9)
153 (20.6)

stroke survivors’ physical health and overall HRQoL. Further,
pre-stroke WMH burden (Senda et al., 2016; Helenius et al.,
2017), presence of multiple lacune (Arauz et al., 2003), CMB
(Charidimou et al., 2016), or moderate-to-severe EPVS in the
basal ganglia (Yang et al., 2016) were all found to be risk
factors for functional disability after stroke. A combination
of SVD markers better predicted poststroke physical outcome
than one marker (Yang et al., 2016; Arba et al., 2017). Arba
et al. (2017) reported that a SVD score, a combination of
WMH, lacunes and brain atrophy based on computerized
tomography scans, was associated with disability at 90 days
after stroke in patients receiving intravenous thrombolysis.
However, none of the above studies combined all 4 SVD markers
based on MRI to evaluate the total brain damage caused by
SVD. More recently, similar to our rating method on SVD
burden, a prospective study of lacunar stroke demonstrated
the role of SVD burden in depression at 3 months after
stroke (Zhang et al., 2016). Another two large-scale studies
of patients with acute ischemic stroke found that SVD
burden could be an imaging marker predicting mortality
after stroke (Song et al., 2017) and stroke recurrence (Lau
et al., 2017). This study extended the above findings by
considering all the markers of SVD and the domain-specific
HRQoL.

127 (17.1)
276 (37.1)
258 (34.7)
91 (12.2)
366 (49.3)
167 (22.5)
119 (16.0)
68 (9.2)
23 (3.1)
104 (94–127)

BI, Barthel Index; CMB, cerebral microbleeds; EPVS, enlarged perivascular
space; HADS-AS, Hospital Anxiety and Depression Scale-Anxiety Subscale; IQR,
interquartile range; LSNS, Lubben Social Network Scale; MMSE, Mini-Mental State
Examination; NIHSS, National Institutes of Health Stroke Scale; SD, standard
deviation; SVD, small vessel diseases; WMH, white matter hyperintensities.

The main findings of this study—SVD burden and the
individual SVD markers of WMH and EPVS are predictors
of HRQoL—are in line with earlier results that lobar CMB
(Tang et al., 2011) and WMH (Tang et al., 2013) impact on

TABLE 3 | Multivariate linear models on the association between SVD burden and the SSQoL.
Model 1: SSQoL Totala

Functional independence (BI)
Anxious symptoms (HADS-AS)
Depressive symptoms (GDS)
Acute infract volume
Infratentorial acute infarct
SVD burden (SVD score)
R2

Model 2: SSQoL Mobilitya

Model 3: SSQoL Visona

B

SE

p

B

SE

p

B

SE

p

5.69
−1.13
−3.41
−1.44
−
−1.39
0.63

0.34
0.23
0.22
0.54
−
0.56

<0.001
<0.001
<0.001
0.01
−
0.01

1.36
−
−0.13
−
−0.67
−0.49
0.53

0.06
−
0.04
−
0.32
0.10

<0.001
−
<0.001
−
0.04
<0.001

0.14
−0.05
−0.07
−

0.03
0.02
0.02
−

<0.001
0.02
<0.001
−

−0.12
0.10

0.06

0.03

BI, Barthel Index; HADS-AS, Hospital Anxiety and Depression Scale-Anxiety Subscale; MMSE, Mini-Mental State Examination; NIHSS, National Institute of Health Stroke
Scale; SE, standard error; SSQoL, Stroke-Specific Quality of Life; SVD, small vessel diseases. a Model 1, 2 and 3 were multivariate linear regressions models adjusted for
age, sex, education, history of stroke, hypertension, diabetes mellitus and hyperlipidemia, NIHSS on admission, BI, HADS-AS, GDS, MMSE, acute infarct volume, acute
infarct locations (cortical, subcortical and infratentorial), presence of old infarct and SVD score with forward selection method (only the significant predictors were listed
here).
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found to contribute modestly to the prediction of domains of
applied cognition–general concerns of HRQoL, however, this
study did not explore the locations of acute infarct (Lin et al.,
2017). Our study showed that the infratentorial acute infarct
could negatively affect several domains of SSQoL, implicating a
necessity of incorporation of the locations of infarcts or other
brain lesions when investigating their impacts on HRQoL after
stroke.
Several strengths and weaknesses of the present study
should be addressed. The major strength is the large, carefully
selected, homogenous sample. Additionally, this study utilized
comprehensive information about SVD by combining all
4 neuroimaging markers into a single ‘‘SVD score’’. A wide range
of confounding factors were considered including demographic,
clinical and the characteristics of infarcts. However, the first
major limitation is that the sample comprised patients mainly
with mild and moderate stroke, among whom a large proportion
had a SVD score of 0. This might limit the generalizability of
the results to more severely affected patients. Second, due to
insufficient clinical information, the diagnosis of stroke subtypes
was not considered in the analysis. Lastly, the study evaluated
patients’ HRQoL after the relatively short post-stroke interval of
3 months, thereby failing to elucidate the long-term impact of
SVD on the HRQoL.
In conclusion, this study found that SVD burden, a
combination of four SVD markers, predicted lower HRQoL,
particularly the dimensions of mobility and vision examined at
3 months after acute ischemic stroke. The findings suggest that
screening baseline SVD burden might help to identify stroke
patients with poor poststroke HRQoL, particularly in the physical
and visual functioning domains, who would benefit from more
focused treatment and rehabilitation strategies. Further studies
are warranted to validate these findings and investigate the
long-term impact of SVD burden on poststroke HRQoL.

Several lines of evidence could explain the negative effect of
SVD burden on overall HRQoL and mobility. Pre-existing SVD
has been suggested to be a marker of brain frailty to ischemia,
as SVD markers indicates accumulating pathologic injuries in
the brain’s small perforating vessels (Wardlaw et al., 2013b).
At the immediate onset of acute ischemia, a more extensive
WMH increases the infarcts’ volume by aggravating the systemic
inflammation or hypercoagulability triggered by ischemia
(Helenius et al., 2017). A high CMB burden increases the risk
of developing symptomatic hemorrhages after revascularization
(Tsivgoulis et al., 2016). Moreover, a greater SVD burden might
slow down the brain’s recovery from stroke. The brain’s ability
to recover is related to the integrity of neural networks. In
the context of extensive SVD, the structural network in the
white matter is disrupted thus impairing the brain’s plasticity
and compensatory mechanisms (Kim et al., 2015; Helenius
et al., 2017). From a clinical point of view, stroke patients
with a higher SVD burden are therefore more predisposed
to functional disabilities and are less likely to recover from
stroke.
Visual functions have been rarely investigated in stroke. An
association between SVD burden and the visual functioning
was found in this study. Consistent with this finding,
visual impairments commonly occur in cerebral autosomal
dominant arteriopathy presenting with subcortical infarcts
and leukoencephalopathy (CADASIL), an inherited adult-onset
disease of cerebral SVD. Retinal microvascular abnormalities
are also commonly reported in patients with sporadic cerebral
SVD (Kwa et al., 2002). In a cross-sectional study of patients
with type 2 diabetes, a close association between diabetic
retinopathy and WMH or lacunes was observed (Sanahuja
et al., 2016). The above findings support the hypothesis
that retinal microvascular diseases and cerebral SVD are
two different manifestations originated from one common
pathologic entity sharing similar risk factors (Kwa et al.,
2002). These findings could explain why cerebral SVD burden
negatively affected domains of vision of SSQoL in the current
study.
About half of this study sample had low SVD burden, similar
to the figure of 45%–50% reported in two cohort studies on
all subtypes of acute ischemic stroke (Lau et al., 2017; Song
et al., 2017). However, in the lacunar stroke population, the SVD
burden was higher with just 30% of subjects with a SVD score of
0 (Huijts et al., 2013). SVD burden is related to a slightly higher
risk for recurrent stroke in stroke accounted to SVD compared to
other etiologies (Lau et al., 2017). It is, therefore, possible that the
impact of SVD burden on poststroke HRQoL may vary across
the different subtypes of acute ischemic stroke. However, the
current study lacked such information on the etiologic subtypes
of ischemeic stroke and therefore was unable to delineate the
contribution of SVD burden in HRQoL by stroke subtype.
In the present study, functional independence, anxiety and
depressive symptoms were found to be predictors of HRQoL,
a finding that has been consistently reported (Raju et al., 2010;
Sprigg et al., 2013). Of note, the size and locations of acute infarct
was significantly associated with one or more domains of HRQoL
in this study. Consistently, the acute infarcts’ volume was recently

Frontiers in Aging Neuroscience | www.frontiersin.org

AUTHOR CONTRIBUTIONS
W-KT and YL made substantial contributions to the conception
and design of the work. YL, Y-KC, MD, VCTM, D-FW and
CWC made substantial contributions to the acquisition of data
for the work. YL and Y-KC made substantial contributions to
the analysis of data. VCTM, D-FW, CWC, GSU, AK and W-KT
contributed to interpretations of data for the work. YL drafted the
article, while all remaining authors critically revised the draft for
intellectual content. All authors gave their approval of the version
to be published, and agreed to be accountable for all aspects of
the work in ensuring that questions related to the accuracy or
integrity of any part of the work were appropriately investigated
and resolved.

FUNDING
This study was supported by the National Natural Science
Foundation of China (Grant Reference Number: 81371460), and
the General Research Fund grant (Grant Reference Number:
473712).

6

November 2017 | Volume 9 | Article 372

Liang et al.

Poststroke Quality of Life

ACKNOWLEDGMENTS

SUPPLEMENTARY MATERIAL

We would like to thank Professor Craig Anderson (The George
Institute for Global Health, Newtown, NSW, Australia) for his
valuable comments on the initial draft of the manuscript.

The Supplementary Material for this article can be found online
at: https://www.frontiersin.org/articles/10.3389/fnagi.2017.003
72/full#supplementary-material

REFERENCES

in patients with ischemic stroke. Stroke 47, 160–166. doi: 10.1161/strokeaha.
116.012885
Song, T. J., Kim, J., Song, D., Yoo, J., Lee, H. S., Kim, Y. J., et al. (2017). Total
cerebral small-vessel disease score is associated with mortality during follow-up
after acute ischemic stroke. J. Clin. Neurol. 13, 187–195. doi: 10.3988/jcn.2017.
13.2.187
Sprigg, N., Selby, J., Fox, L., Berge, E., Whynes, D., and Bath, P. M. (2013). Very
low quality of life after acute stroke: data from the efficacy of nitric oxide in
stroke trial. Stroke 44, 3458–3462. doi: 10.1161/strokeaha.113.002201
Staals, J., Makin, S. D., Doubal, F. N., Dennis, M. S., and Wardlaw, J. M.
(2014). Stroke subtype, vascular risk factors, and total MRI brain smallvessel disease burden. Neurology 83, 1228–1234. doi: 10.1212/wnl.000000000
0000837
Tang, W. K., Chen, Y. K., Lu, J., Ahuja, A. T., Chu, W. C., Mok, V. C., et al. (2011).
Cerebral microbleeds and quality of life in acute ischemic stroke. Neurol. Sci.
32, 449–454. doi: 10.1007/s10072-011-0571-y
Tang, W. K., Liang, H. J., Chen, Y. K., Ahuja, A. T., Chu, W. C., Mok, V. C., et al.
(2013). White matter hyperintensities and quality of life in acute lacunar stroke.
Neurol. Sci. 34, 1347–1353. doi: 10.1007/s10072-012-1267-7
Tsivgoulis, G., Zand, R., Katsanos, A. H., Turc, G., Nolte, C. H., Jung, S.,
et al. (2016). Risk of symptomatic intracerebral hemorrhage after
intravenous thrombolysis in patients with acute ischemic stroke and high
cerebral microbleed burden: a meta-analysis. JAMA Neurol. 73, 675–683.
doi: 10.1001/jamaneurol.2016.0292
Uiterwijk, R., van Oostenbrugge, R. J., Huijts, M., De Leeuw, P. W.,
Kroon, A. A., and Staals, J. (2016). Total cerebral small vessel disease MRI
score is associated with cognitive decline in executive function in patients
with hypertension. Front. Aging Neurosci. 8:301. doi: 10.3389/fnagi.2016.
00301
Wang, Y., Ma, J., and Li, J. (2003). The study on reliability, validity and
responsiveness of the Chinese version of stroke-specific quality of life. Chin.
J. Geriatr. Heart. Brain. Vessel. Dis. 5, 391–394.
Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R.,
et al. (2013a). Neuroimaging standards for research into small vessel disease
and its contribution to ageing and neurodegeneration. Lancet Neurol. 12,
822–838. doi: 10.1016/S1474-4422(13)70124-8
Wardlaw, J. M., Smith, C., and Dichgans, M. (2013b). Mechanisms of sporadic
cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 12,
483–497. doi: 10.1016/s1474-4422(13)70060-7
Yang, H., Shen, R., Jin, Z., Li, J., Wu, Y., Xu, Y., et al. (2016). Dilated
virchow-robin spaces in first-ever lacunar stroke patients: topography and
clinical correlations. J. Stroke Cerebrovasc. Dis. 25, 306–311. doi: 10.1016/j.
jstrokecerebrovasdis.2015.09.034
Zhang, X., Tang, Y., Xie, Y., Ding, C., Xiao, J., Jiang, X., et al. (2016). Total magnetic
resonance imaging burden of cerebral small-vessel disease is associated with
post-stroke depression in patients with acute lacunar stroke. Eur. J. Neurol. 24,
374–380. doi: 10.1111/ene.13213

Ali, M., Fulton, R., Quinn, T., Brady, M., and VISTA Collaboration. (2013). How
well do standard stroke outcome measures reflect quality of life? A retrospective
analysis of clinical trial data. Stroke 44, 3161–3165. doi: 10.1161/STROKEAHA.
113.001126
Arauz, A., Murillo, L., Cantu, C., Barinagarrementeria, F., and Higuera, J. (2003).
Prospective study of single and multiple lacunar infarcts using magnetic
resonance imaging: risk factors, recurrence, and outcome in 175 consecutive
cases. Stroke 34, 2453–2458. doi: 10.1161/01.str.0000090351.41662.91
Arba, F., Inzitari, D., Ali, M., Warach, S. J., Luby, M., and Lees, K. R. (2017). Small
vessel disease and clinical outcomes after IV rt-PA treatment. Acta Neurol.
Scand. 136, 72–77. doi: 10.1111/ane.12745
Charidimou, A., Shoamanesh, A., and International META-MICROBLEEDS
Initiative. (2016). Clinical relevance of microbleeds in acute stroke
thrombolysis: comprehensive meta-analysis. Neurology 87, 1534–1541.
doi: 10.1212/wnl.0000000000003207
Fazekas, F., Chawluk, J. B., Alavi, A., Hurtig, H. I., and Zimmerman, R. A. (1987).
MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging.
Am. J. Roentgenol. 149, 351–356. doi: 10.2214/ajr.149.2.351
Helenius, J., Mayasi, Y., and Henninger, N. (2017). White matter hyperintensity
lesion burden is associated with the infarct volume and 90-day outcome in
small subcortical infarcts. Acta Neurol. Scand. 135, 585–592. doi: 10.1111/ane.
12670
Huijts, M., Duits, A., van Oostenbrugge, R. J., Kroon, A. A., de Leeuw, P. W.,
and Staals, J. (2013). Accumulation of MRI markers of cerebral small
vessel disease is associated with decreased cognitive function. A study in
first-ever lacunar stroke and hypertensive patients. Front. Aging Neurosci. 5:72.
doi: 10.3389/fnagi.2013.00072
Kim, H. J., Im, K., Kwon, H., Lee, J. M., Kim, C., Kim, Y. J., et al. (2015). Clinical
effect of white matter network disruption related to amyloid and small vessel
disease. Neurology 85, 63–70. doi: 10.1212/wnl.0000000000001705
Kim, B. J., and Lee, S. H. (2015). Prognostic impact of cerebral small vessel disease
on stroke outcome. J. Stroke 17, 101–110. doi: 10.5853/jos.2015.17.2.101
Kwa, V. I., van der Sande, J. J., Stam, J., Tijmes, N., Vrooland, J. L., and Amsterdam
Vascular Medicine Group. (2002). Retinal arterial changes correlate with
cerebral small-vessel disease. Neurology 59, 1536–1540. doi: 10.1212/01.wnl.
0000033093.16450.5c
Lau, K. K., Li, L., Schulz, U., Simoni, M., Chan, K. H., Ho, S. L., et al. (2017).
Total small vessel disease score and risk of recurrent stroke: validation in 2 large
cohorts. Neurology 88, 2260–2267. doi: 10.1212/wnl.0000000000004042
Lin, C., Lee, J., Chatterjee, N., Corado, C., Carroll, T., Naidech, A., et al. (2017).
Predicting domain-specific health-related quality of life using acute infarct
volume. Stroke 48, 1925–1931. doi: 10.1161/strokeaha.117.017094
Potter, G. M., Chappell, F. M., Morris, Z., and Wardlaw, J. M. (2015). Cerebral
perivascular spaces visible on magnetic resonance imaging: development of
a qualitative rating scale and its observer reliability. Cerebrovasc. Dis. 39,
224–231. doi: 10.1159/000375153
Raju, R. S., Sarma, P. S., and Pandian, J. D. (2010). Psychosocial problems, quality
of life, and functional independence among Indian stroke survivors. Stroke 41,
2932–2937. doi: 10.1161/strokeaha.110.596817
Sanahuja, J., Alonso, N., Diez, J., Ortega, E., Rubinat, E., Traveset, A., et al. (2016).
Increased burden of cerebral small vessel disease in patients with type 2 diabetes
and retinopathy. Diabetes Care 39, 1614–1620. doi: 10.2337/dc15-2671
Sato, S., Delcourt, C., Heeley, E., Arima, H., Zhang, S., Al-Shahi Salman, R.,
et al. (2016). Significance of cerebral small-vessel disease in acute intracerebral
hemorrhage. Stroke 47, 701–707. doi: 10.1161/strokeaha.115.012147
Senda, J., Ito, K., Kotake, T., Kanamori, M., Kishimoto, H., Kadono, I., et al.
(2016). Association of leukoaraiosis with convalescent rehabilitation outcome

Frontiers in Aging Neuroscience | www.frontiersin.org

Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Liang, Chen, Deng, Mok, Wang, Ungvari, Chu, Kamiya and Tang.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.

7

November 2017 | Volume 9 | Article 372

